CF
IDXX icon

Centaurus Financial’s Idexx Laboratories IDXX Stock Holding History

Centaurus Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407K Hold
725
– – 0.02% 585
2025
Q4 		$490K Sell
725
-5
-0.7% -$3.4K 0.02% 535
2025
Q3 		$466K Sell
730
-24
-3% -$14.6K 0.02% 554
2025
Q2 		$404K Sell
754
-154
-17% -$73.6K 0.02% 534
2025
Q1 		$381K Buy
908
+628
+224% +$273K 0.02% 521
2024
Q4 		$116K Buy
280
+53
+23% +$23.2K 0.01% 830
2024
Q3 		$115K Buy
+227
New +$110K 0.01% 788
2022
Q2 		– Sell
-200
Closed -$109K – 870
2022
Q1 		$109K Hold
200
– – 0.01% 845
2021
Q4 		$132K Hold
200
– – 0.01% 809
2021
Q3 		$124K Buy
+200
New +$134K 0.01% 794

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centaurus Financial's IDXX Position: Q1 2026 in Review

Centaurus Financial held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 725 shares worth $407K. The position accounts for 0.02% of the portfolio, ranked #585.

Centaurus Financial first reported a position in IDXX in Q3 2021 and has held it in 10 quarters since. The position peaked at $490K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Centaurus Financial held 725 shares of Idexx Laboratories worth $407K as of Q1 2026.
  • Centaurus Financial left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.02% of Centaurus Financial's portfolio in Q1 2026, its #585 holding.
  • Centaurus Financial first reported a position in Idexx Laboratories in Q3 2021 and has held it in 10 quarters since.
  • Centaurus Financial's Idexx Laboratories position peaked at $490K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.